NCT00944268View on ClinicalTrials.gov

Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

PHASE3UnknownINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
AnxietyEfficacyTolerability
Interventions
DRUG

Passiflora, Crataegus e Salix

Comparison of different pharmaceutics forms of drug

Trial Locations (1)

09060650

Faculdade de Medicina do ABC, Santo André

Sponsors
All Listed Sponsors
lead

Ativus Farmaceutica Ltda

INDUSTRY

NCT00944268 - Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety | Biotech Hunter | Biotech Hunter